{"id":"10rca","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Buddhist Tzu Chi General Hospital","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":["Pariet x 10 days","Klaricid x 10 days","Hiconcil x 10 days."],"company":"Buddhist Tzu Chi General Hospital","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=10RCA","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:00:41.667112+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:00:47.546727+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=10RCA","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:00:48.311121+00:00"}},"allNames":["10rca"],"offLabel":[],"synonyms":[],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"10rca is a small molecule that binds to a specific protein or receptor in the body, altering its function and leading to a therapeutic response. The exact mechanism of action is unknown, but it is thought to involve modulation of a signaling pathway or interaction with a molecular target."},"commercial":{},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=10rca","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=10rca","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:31:41.687653","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:00:50.467651+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"10rca","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT01573975","phase":"PHASE4","title":"Comparison Between Ten Days Sequential Treatment and Traditional Three Combined Treatment of Helicobacter Pylori","status":"COMPLETED","sponsor":"Buddhist Tzu Chi General Hospital","startDate":"2009-01","conditions":["Helicobacter Pylori Infection"],"enrollment":345,"completionDate":"2011-05"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Buddhist Tzu Chi General Hospital","relationship":"Original Developer"}],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"originalDeveloper":"Buddhist Tzu Chi General Hospital","recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"10RCA","companyName":"Buddhist Tzu Chi General Hospital","companyId":"buddhist-tzu-chi-general-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:00:50.467651+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}